Chimeric Therapeutics Ltd (CHM) - Cash Flow Conversion Efficiency

Latest as of December 2025: 1.268x

Based on the latest financial reports, Chimeric Therapeutics Ltd (CHM) has a cash flow conversion efficiency ratio of 1.268x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.84 Million ≈ $-2.72 Million USD) by net assets (AU$-3.03 Million ≈ $-2.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Chimeric Therapeutics Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Chimeric Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Chimeric Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chimeric Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chimeric Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Olivut Resources Ltd V:OLV	-0.350x
TMM REAL EST.DEV.GDR S 1 F:TR61	N/A
M N C Wireless Bhd KLSE:0103	0.187x
Boxlight Corp Class A NASDAQ:BOXL	2.511x
CLS Holdings plc LSE:CLI	0.012x
Sure-Tech Investments LP TA:STEC	-0.038x
MW Trade S.A. WAR:MWT	-0.064x
Dart Mining NL AU:DTM	-0.035x

Annual Cash Flow Conversion Efficiency for Chimeric Therapeutics Ltd (2020–2025)

The table below shows the annual cash flow conversion efficiency of Chimeric Therapeutics Ltd from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Chimeric Therapeutics Ltd (CHM) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.97 Million ≈ $1.40 Million	AU$-7.28 Million ≈ $-5.15 Million	-3.685x	-20.75%
2024-06-30	AU$2.47 Million ≈ $1.75 Million	AU$-7.54 Million ≈ $-5.33 Million	-3.052x	-5.87%
2023-06-30	AU$5.66 Million ≈ $4.01 Million	AU$-16.32 Million ≈ $-11.54 Million	-2.882x	-463.33%
2022-06-30	AU$25.71 Million ≈ $18.19 Million	AU$-13.15 Million ≈ $-9.31 Million	-0.512x	-45.42%
2021-06-30	AU$25.13 Million ≈ $17.78 Million	AU$-8.84 Million ≈ $-6.26 Million	-0.352x	-166.12%
2020-06-30	AU$-63.91K ≈ $-45.22K	AU$-34.01K ≈ $-24.06K	0.532x	--

About Chimeric Therapeutics Ltd

AU:CHM Australia Biotechnology

Market Cap

$2.38 Million

AU$3.37 Million AUD

Market Cap Rank

#29763 Global

#1739 in Australia

Share Price

AU$0.07

Change (1 day)

-7.14%

52-Week Range

AU$0.00 - AU$0.21

All Time High

AU$0.39